155 related articles for article (PubMed ID: 21094812)
1. Prevalence and predictive factors of anemia after renal transplantation: a Moroccan report.
Radoui A; Skalli Z; Haddiya I; Benamar L; Ezzaitouni F; Ouzeddoun N; Bayahia R; Rhou H
Transplant Proc; 2010 Nov; 42(9):3542-9. PubMed ID: 21094812
[TBL] [Abstract][Full Text] [Related]
2. Anemia at 1 year after kidney transplantation has a negative long-term impact on graft and patient outcomes.
Marcén R; Galeano C; Fernandez-Rodriguez A; Jiménez S; Teruel JL; Burgos FJ; Quereda C
Transplant Proc; 2012 Nov; 44(9):2593-5. PubMed ID: 23146465
[TBL] [Abstract][Full Text] [Related]
3. Impact of very early high doses of recombinant erythropoietin on anemia and allograft function in de novo kidney-transplant patients.
Kamar N; Reboux AH; Cointault O; Esposito L; Cardeau-Desangles I; Lavayssière L; Guitard J; Wéclawiak H; Rostaing L
Transpl Int; 2010 Mar; 23(3):277-84. PubMed ID: 19821956
[TBL] [Abstract][Full Text] [Related]
4. Proteinuria is a predictor of posttransplant anemia.
Bonofiglio R; Lofaro D; Greco R; Senatore M; Papalia T
Transplant Proc; 2011 May; 43(4):1063-6. PubMed ID: 21620053
[TBL] [Abstract][Full Text] [Related]
5. Unexpectedly high prevalence of posttransplant anemia in pediatric and young adult renal transplant recipients.
Yorgin PD; Belson A; Sanchez J; Al Uzri AY; Sarwal M; Bloch DA; Oehlert J; Salvatierra O; Alexander SR
Am J Kidney Dis; 2002 Dec; 40(6):1306-18. PubMed ID: 12460052
[TBL] [Abstract][Full Text] [Related]
6. Early risk factors for persistent anemia after kidney transplantation.
Schonder KS; Corman SL; Hung WY
Pharmacotherapy; 2010 Dec; 30(12):1214-20. PubMed ID: 21114388
[TBL] [Abstract][Full Text] [Related]
7. Anemia after kidney transplantation; its prevalence, risk factors, and independent association with graft and patient survival: a time-varying analysis.
Jones H; Talwar M; Nogueira JM; Ugarte R; Cangro C; Rasheed H; Klassen DK; Weir MR; Haririan A
Transplantation; 2012 May; 93(9):923-8. PubMed ID: 22377790
[TBL] [Abstract][Full Text] [Related]
8. Association of serum phosphorus level with anemia in kidney transplant recipients.
Kovesdy CP; Mucsi I; Czira ME; Rudas A; Ujszaszi A; Rosivall L; Kim SJ; Wolf M; Molnar MZ
Transplantation; 2011 Apr; 91(8):875-82. PubMed ID: 21358369
[TBL] [Abstract][Full Text] [Related]
9. Posttransplantation anemia: mechanisms and management.
Yabu JM; Winkelmayer WC
Clin J Am Soc Nephrol; 2011 Jul; 6(7):1794-801. PubMed ID: 21734096
[TBL] [Abstract][Full Text] [Related]
10. The influence of pre-operative electrocardiographic abnormalities and cardiovascular risk factors on patient and graft survival following renal transplantation.
Woo YM; McLean D; Kavanagh D; Ward L; Aitken S; Miller GJ; Egan P; Hughes K; Clark L; Carswell K; Morris ST; Northridge DB; Rodger RS; Jardine AG
J Nephrol; 2002; 15(4):380-6. PubMed ID: 12243367
[TBL] [Abstract][Full Text] [Related]
11. Impact of cardiovascular risk factors on the outcome of renal transplantation.
Moghimi M; Falaknazi K; Bagheri N
Saudi J Kidney Dis Transpl; 2010 May; 21(3):438-42. PubMed ID: 20427865
[TBL] [Abstract][Full Text] [Related]
12. Post transplantation anemia: re-emphasizing the use of erythropoietin.
Jabur WL
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):104-6. PubMed ID: 21196622
[No Abstract] [Full Text] [Related]
13. A prospective protocol-based trial of darbepoetin alfa therapy to correct the early anemia following renal transplantation.
Pankewycz O; Kulaylat M; Fagan L; Matthews B; Kohli R; Laftavi MR
Transplant Proc; 2010 Nov; 42(9):3537-41. PubMed ID: 21094811
[TBL] [Abstract][Full Text] [Related]
14. Long-acting erythropoietin stimulating agents for persistent anemia after kidney transplant: risk factors and outcome.
Al-Otaibi T; Gheith O; Halim MA; Abu Attia H; Mansour H; Said T; Nair P; Balaha M; Nampoory MR
Exp Clin Transplant; 2014 Jun; 12(3):220-6. PubMed ID: 24907722
[TBL] [Abstract][Full Text] [Related]
15. Posttransplantation anemia: relationship with inflammatory markers, oxidation, and prohepcidin levels.
Sancho A; Pastor MC; Cañas L; Morales Indiano C; Ardèvol M; Aguerrevere S; Juega J; Romero R; Lauzurica R
Transplant Proc; 2011; 43(6):2196-8. PubMed ID: 21839232
[TBL] [Abstract][Full Text] [Related]
16. Anemia after kidney transplantation in adult recipients: prevalence and risk factors.
Einollahi B; Lessan-Pezeshki M; Rostami Z; Kalantar E; Afshar R; Beiraghdar F
Transplant Proc; 2011 Mar; 43(2):578-80. PubMed ID: 21440766
[TBL] [Abstract][Full Text] [Related]
17. Anemia in living donor kidney transplantation.
Sert I; Colak H; Tugmen C; Dogan SM; Karaca C
Transplant Proc; 2013; 45(6):2238-43. PubMed ID: 23714109
[TBL] [Abstract][Full Text] [Related]
18. Posttransplant anemia in solid organ recipients.
Blosser CD; Bloom RD
Transplant Rev (Orlando); 2010 Apr; 24(2):89-98. PubMed ID: 20303457
[TBL] [Abstract][Full Text] [Related]
19. Prevalence evolution and impact of cardiovascular risk factors on allograft and renal transplant patient survival.
Díaz JM; Gich I; Bonfill X; Solà R; Guirado L; Facundo C; Sainz Z; Puig T; Silva I; Ballarín J
Transplant Proc; 2009; 41(6):2151-5. PubMed ID: 19715859
[TBL] [Abstract][Full Text] [Related]
20. Treatment of anemia in renal transplantation: impact of a stricter application of hemoglobin targets.
Gentil MA; Pérez-Valdivia MA; González-Roncero FM; López-Mendoza M; Cabello V; Bernal G; Suñer M; Pereira P
Transplant Proc; 2008 Nov; 40(9):2916-8. PubMed ID: 19010146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
